Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 802 of 1,261

  1. US 8785377

    Tetrazolyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  2. US 8785407

    Antisense antiviral agent and method for treating ssRNA viral infection

    Sarepta Therapeutics, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  3. US 8785409

    Compounds having anti-adhesive effects on cancer cells

    The Board of Regents of the University of Texas System · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  4. US 8785410

    Antisense composition and method for treating muscle atrophy

    Sarepta Therapeutics, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  5. US 8785437

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  6. US 8785421

    Use of vitamin D in dairy mastitis treatment

    The United States of America, as represented by the Secretary of Agriculture · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  7. US 8785429

    Dihydropyrrolonaphthyridinone compounds as inhibitors of JAK

    Takeda Pharmaceutical Company Limited · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  8. US 8785442

    Compound as antagonist of lysophosphatidic acid receptor, composition, and use thereof

    Curegenix, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  9. US 8785449

    Carboxamide compounds and methods for using the same

    Rigel Pharmaceuticals, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  10. US 8785460

    Tricyclic compounds and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  11. US 8785486

    Imidazo[1,2-A]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors

    Addex Pharma, S.A. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  12. US 8785483

    Methods for treating COPD

    The Board of Regents of the University of Texas System · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  13. US 8784866

    Water-soluble carbon nanotube compositions for drug delivery and medicinal applications

    The Board of Regents of the University of Texas System · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  14. US 8784870

    Controlled release compositions for modulating free-radical induced damage and methods of use thereof

    The Regents of the University of California · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  15. US 8784791

    Method for preparing water-soluble polymer derivatives bearing an N-succinimidyl ester

    Nektar Therapeutics · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  16. US 8784895

    Multifunctional metal nanoparticles having a polydopamine-based surface and methods of making and using the same

    Northwestern University · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  17. US 8785444

    Thiazoles and pyrazoles useful as kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  18. US 8785393

    Ophthalmic pharmaceutical compositions of DP2 receptor antagonists

    Panmira Pharmaceuticals, LLC · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  19. US 8785191

    Concentration of stem cells obtained during orthopaedic surgeries

    UNIVERSITY OF CONNECTICUT · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  20. US 8785450

    Therapeutic compounds and compositions

    Agios Pharmaceuticals, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  21. US 8785640

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  22. US 8784780

    High oil-content emollient aerosol foam compositions

    Precision Dermatology, Inc. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  23. US 8785414

    Differentially expressed microRNAs as biomarkers for the diagnosis and treatment of Sjögren's syndrome

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

  24. US 8784817

    Method for killing IL-1 alpha expressing cells

    XBIOTECH INC. · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.